Literature DB >> 19748647

Effective activation alleviates the replication block of CCR5-tropic HIV-1 in chimpanzee CD4+ lymphocytes.

Julie M Decker1, Kenneth P Zammit, Juliet L Easlick, Mario L Santiago, Denise Bonenberger, Beatrice H Hahn, Olaf Kutsch, Frederic Bibollet-Ruche.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) originated in chimpanzees; yet, several previous studies have shown that primary HIV-1 isolates replicate poorly in chimpanzee CD4+ T lymphocytes in vitro and in vivo. The reasons for this apparent restriction are not understood. Here, we describe a new activation protocol that led to a reproducible expansion and activation of chimpanzee CD4+ T lymphocytes in vitro. Using this protocol, we uncovered species-specific differences in the activation profiles of human and chimpanzee CD4+ T-cells, including HLA-DR and CD62L. Moreover, we found that improved activation facilitated the replication of both CXCR4 and CCR5-tropic HIV-1 in CD4+ T-cell cultures from over 30 different chimpanzees. Thus, the previously reported "replication block" of CCR5-tropic HIV-1 in chimpanzee lymphocytes appears to be due, at least in large part, to suboptimal T-cell activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19748647      PMCID: PMC2767406          DOI: 10.1016/j.virol.2009.08.027

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  90 in total

1.  Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

Authors:  M Mengozzi; M Malipatlolla; S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  Longitudinal comparison of virus load parameters and CD8 T-cell suppressive capacity in two SIVcpz-infected chimpanzees.

Authors:  P Ondoa; L Kestens; D Davis; C Vereecken; B Willems; K Fransen; J Vingerhoets; G Zissis; P ten Haaft; J Heeney; G van der Groen
Journal:  J Med Primatol       Date:  2001-10       Impact factor: 0.667

3.  In vitro susceptibility to infection with SIVcpz and HIV-1 is lower in chimpanzee than in human peripheral blood mononuclear cells.

Authors:  Pascale Ondoa; David Davis; Luc Kestens; Chris Vereecken; Sergio Garcìa Ribas; Katrien Fransen; Jonathan Heeney; Guido van der Groen
Journal:  J Med Virol       Date:  2002-07       Impact factor: 2.327

4.  A strong signature of balancing selection in the 5' cis-regulatory region of CCR5.

Authors:  Michael J Bamshad; Srinivas Mummidi; Enrique Gonzalez; Seema S Ahuja; Diane M Dunn; W Scott Watkins; Stephen Wooding; Anne C Stone; Lynn B Jorde; Robert B Weiss; Sunil K Ahuja
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-29       Impact factor: 11.205

5.  Differences in early virus loads with different phenotypic variants of HIV-1 and SIV(cpz) in chimpanzees.

Authors:  P ten Haaft; K Murthy; M Salas; H McClure; R Dubbes; W Koornstra; H Niphuis; D Davis; G van der Groen; J Heeney
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

6.  Allelic variants of human beta-chemokine receptor 5 (CCR5) promoter: evolutionary relationships and predictable associations with HIV-1 disease progression.

Authors:  J Tang; C Rivers; E Karita; C Costello; S Allen; P N Fultz; E E Schoenbaum; R A Kaslow
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

7.  Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

Authors:  Yea-Lih Lin; Clement Mettling; Pierre Portales; Jacques Reynes; Jacques Clot; Pierre Corbeau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

8.  Donor- and ligand-dependent differences in C-C chemokine receptor 5 reexpression.

Authors:  R Sabbe; G R Picchio; C Pastore; O Chaloin; O Hartley; R Offord; D E Mosier
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

9.  Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

Authors:  Xiping Wei; Julie M Decker; Hongmei Liu; Zee Zhang; Ramin B Arani; J Michael Kilby; Michael S Saag; Xiaoyun Wu; George M Shaw; John C Kappes
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  8 in total

1.  Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.

Authors:  Rui Kong; Hui Li; Frederic Bibollet-Ruche; Julie M Decker; Natalie N Zheng; Geoffrey S Gottlieb; Nancy B Kiviat; Papa Salif Sow; Ivelin Georgiev; Beatrice H Hahn; Peter D Kwong; James E Robinson; George M Shaw
Journal:  J Virol       Date:  2011-10-26       Impact factor: 5.103

2.  Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation.

Authors:  Frederic Bibollet-Ruche; Anke Heigele; Brandon F Keele; Juliet L Easlick; Julie M Decker; Jun Takehisa; Gerald Learn; Paul M Sharp; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

3.  Macrophages sustain HIV replication in vivo independently of T cells.

Authors:  Jenna B Honeycutt; Angela Wahl; Caroline Baker; Rae Ann Spagnuolo; John Foster; Oksana Zakharova; Stephen Wietgrefe; Carolina Caro-Vegas; Victoria Madden; Garrett Sharpe; Ashley T Haase; Joseph J Eron; J Victor Garcia
Journal:  J Clin Invest       Date:  2016-03-07       Impact factor: 14.808

4.  Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir.

Authors:  Yingying Li; Jean-Bosco Ndjango; Gerald H Learn; Miguel A Ramirez; Brandon F Keele; Frederic Bibollet-Ruche; Weimin Liu; Juliet L Easlick; Julie M Decker; Rebecca S Rudicell; Bila-Isia Inogwabini; Steve Ahuka-Mundeke; Fabian H Leendertz; Vernon Reynolds; Martin N Muller; Rebecca L Chancellor; Aaron S Rundus; Nicole Simmons; Michael Worobey; George M Shaw; Martine Peeters; Paul M Sharp; Beatrice H Hahn
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

5.  The Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from Monkeys.

Authors:  Lucie Etienne; Frederic Bibollet-Ruche; Peter H Sudmant; Lily I Wu; Beatrice H Hahn; Michael Emerman
Journal:  PLoS Pathog       Date:  2015-09-22       Impact factor: 6.823

6.  Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.

Authors:  Hannah J Barbian; Julie M Decker; Frederic Bibollet-Ruche; Rachel P Galimidi; Anthony P West; Gerald H Learn; Nicholas F Parrish; Shilpa S Iyer; Yingying Li; Craig S Pace; Ruijiang Song; Yaoxing Huang; Thomas N Denny; Hugo Mouquet; Loic Martin; Priyamvada Acharya; Baoshan Zhang; Peter D Kwong; John R Mascola; C Theo Verrips; Nika M Strokappe; Lucy Rutten; Laura E McCoy; Robin A Weiss; Corrine S Brown; Raven Jackson; Guido Silvestri; Mark Connors; Dennis R Burton; George M Shaw; Michel C Nussenzweig; Pamela J Bjorkman; David D Ho; Michael Farzan; Beatrice H Hahn
Journal:  MBio       Date:  2015-04-21       Impact factor: 7.867

7.  CD4 receptor diversity in chimpanzees protects against SIV infection.

Authors:  Frederic Bibollet-Ruche; Ronnie M Russell; Weimin Liu; Guillaume B E Stewart-Jones; Scott Sherrill-Mix; Yingying Li; Gerald H Learn; Andrew G Smith; Marcos V P Gondim; Lindsey J Plenderleith; Julie M Decker; Juliet L Easlick; Katherine S Wetzel; Ronald G Collman; Shilei Ding; Andrés Finzi; Ahidjo Ayouba; Martine Peeters; Fabian H Leendertz; Joost van Schijndel; Annemarie Goedmakers; Els Ton; Christophe Boesch; Hjalmar Kuehl; Mimi Arandjelovic; Paula Dieguez; Mizuki Murai; Christelle Colin; Kathelijne Koops; Sheri Speede; Mary K Gonder; Martin N Muller; Crickette M Sanz; David B Morgan; Rebecca Atencia; Debby Cox; Alex K Piel; Fiona A Stewart; Jean-Bosco N Ndjango; Deus Mjungu; Elizabeth V Lonsdorf; Anne E Pusey; Peter D Kwong; Paul M Sharp; George M Shaw; Beatrice H Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-02-04       Impact factor: 11.205

8.  Cell-intrinsic mechanism involving Siglec-5 associated with divergent outcomes of HIV-1 infection in human and chimpanzee CD4 T cells.

Authors:  Paula C Soto; Maile Y Karris; Celsa A Spina; Douglas D Richman; Ajit Varki
Journal:  J Mol Med (Berl)       Date:  2012-09-04       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.